IHAM
PHVS icon

Integral Health Asset Management’s Pharvaris PHVS Stock Holding History

Integral Health Asset Management’s Portfolio PHVS Stock Details PHVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-200,000
Closed -$4.99M – 100
2025
Q3 		$4.99M Buy
+200,000
New +$4.44M 0.34% 70

Other funds holding PHVS

GA
General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return
VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
EFM
EQT Fund Management Luxembourg $1.02B AUM
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

Integral Health Asset Management's PHVS Position: Q4 2025 in Review

Integral Health Asset Management sold out of Pharvaris (PHVS) in Q4 2025, closing a stake of 200,000 shares — an estimated $4.99M sold.

Integral Health Asset Management first reported a position in PHVS in Q3 2025 and held it in 1 quarter. The position peaked at $4.99M in Q3 2025. 106 funds tracked by Wall St. Rank hold PHVS as of Q4 2025.

  • Integral Health Asset Management reported no remaining Pharvaris position as of Q4 2025 after selling out during the quarter.
  • Integral Health Asset Management sold 200,000 Pharvaris shares in Q4 2025, an estimated $4.99M.
  • Integral Health Asset Management first reported a position in Pharvaris in Q3 2025 and held it in 1 quarter.
  • Integral Health Asset Management's Pharvaris position peaked at $4.99M in Q3 2025.
  • 106 funds tracked by Wall St. Rank held Pharvaris as of Q4 2025.

Based on Integral Health Asset Management's 13F filing for Q4 2025, filed 17 Feb 2026.